Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
DiscussionFor the first time in the Syrian population, this randomized controlled trial will provide objective and accurate evidence about the efficacy of a sequential levofloxacin-based treatment regimen.Trial registrationClinicalTrials.govNCT06065267. Registered on October 3, 2023. Prospective registered. Enrollment of the first participant has not started yet.
Source: Trials - Category: Research Source Type: clinical trials
More News: Amoxicillin | Clinical Trials | Helicobacter Pylori | Levaquin | Proton Pump Inhibitors PPIs | Research | Study | Syria Health